Skip to main content

RT @RichardPAConway: Izmirly et al. HCQ crosses placenta but no evidence ocular toxicity in children at 5 years old by O

Social Author Name
Richard Conway
Tweet Content
Izmirly et al. HCQ crosses placenta but no evidence ocular toxicity in children at 5 years old by OCT @RheumNow #ACR22 Abstr#1674 https://t.co/yMQzt6sU7i

RT @drdavidliew: Chimeric autoantigen-T cell receptor (CATCR)-T cell therapies: precision cellular therapy selectively d

Social Author Name
David Liew
Tweet Content
Chimeric autoantigen-T cell receptor (CATCR)-T cell therapies: precision cellular therapy selectively deplete autoreactive B cells @MaxKonigMD in the plenary: CATCR can take out anti-b2GPI autoAbs crucial to antiphospholipid syndrome, but preserve normal B cells #ACR22 @RheumNow https://t.co/5ZLocrwqKY

RT @JulianSegan: GWAS analysis of 2.5m people (120k with gout) showing identifies 1486 candidate causal genes for gout.

Social Author Name
Julian Segan
Tweet Content
GWAS analysis of 2.5m people (120k with gout) showing identifies 1486 candidate causal genes for gout. Looking at urate handling as well as disease propagation (eg. IL1/6). Widespread GWAS allowing us to investigate these diseases differently. @RheumNow #ACR22 #Plenary

RT @Janetbirdope: #ACR22 Highlights. ILD in CTDs #rituximab = #cyclophoshamide at 6 mo for CTD ILD & ritux better on

Social Author Name
Janet Pope
Tweet Content
#ACR22 Highlights. ILD in CTDs #rituximab = #cyclophoshamide at 6 mo for CTD ILD & ritux better on skin score in #scleroderma RECITAL RCT abst0003 but #pirfenidone added to #MMF not better than MMF alone in SLSIII RCT—ILD w #SSc abst#520 vs in SENCIS #nintedanib is + @RheumNow

RT @EBRheum: Great moderating PMR talk w/@SattuiSEMD this AM; phenomenal slides @drceowen re:imaging in PMR Big ?s: -Wh

Social Author Name
Mike Putman
Tweet Content
Great moderating PMR talk w/@SattuiSEMD this AM; phenomenal slides @drceowen re:imaging in PMR Big ?s: -Who needs this? All/some/many -Which modality? Nice summary slide -How to treat "subclinical" GCA (risk of overtreatment imo) Ideas for next year? #ACR22 @rheumnow #ACRBest https://t.co/akvsud3YVO

RT @DrCassySims: Preterm delivery and HTN disorders in #vasculitis Abstract #0953 #ACR22 @RheumNow @StanfordRheum ðŸ

Social Author Name
Catherine Sims, MD
Tweet Content
Preterm delivery and HTN disorders in #vasculitis Abstract #0953 #ACR22 @RheumNow @StanfordRheum 🤰87 deliveries from 1991-2012 🤰Higher risk for preterm delivery (PTD) (RR 4), PPROM (RR 4), HTN dx of preg. (RR 3) 🤰Of spon. PTD, 17% born between 20-31 weeks

RT @ericdeinmd: Ab1676 #ACR22 SAPHYR: Sarilumab in Refractory PMR 52wk SAR 200 mg q2w + 14w taper GC v PBO+GC taper Prim

Social Author Name
Eric Dein
Tweet Content
Ab1676 #ACR22 SAPHYR: Sarilumab in Refractory PMR 52wk SAR 200 mg q2w + 14w taper GC v PBO+GC taper Primary endpt: sustain response at 52w Early term 2/2 COVID, 117 pt SAR remission 28% vs PBO 10%, p=0.02 Data consistent when removes CRP data PBO: more GCs 2/2 PMR flare @Rheumnow https://t.co/kHq3juULX1

RT @drdavidliew: How much does diet and exercise help in knee osteoarthritis? Pragmatic RCT (WE-CAN), n=823 a diet &amp

Social Author Name
David Liew
Tweet Content
How much does diet and exercise help in knee osteoarthritis? Pragmatic RCT (WE-CAN), n=823 a diet & exercise intervention program led to: - 10kg weight loss - some significant pain improvements We need to fund diet & exercise programs for OA patients! ABST1675 #ACR22 @RheumNow https://t.co/Ctm8ZoRF3o

RT @synovialjoints: Update on ACR Guideline on Prevention and Treatment of GIOP. Sequential Rx when initial OP Rx and

Social Author Name
Dr. Antoni Chan
Tweet Content
Update on ACR Guideline on Prevention and Treatment of GIOP. Sequential Rx when initial OP Rx and GC discontinued https://t.co/TWdI728pCp Mary Beth Humphrey #ACR22 @RheumNow https://t.co/i320si4RJp
Subscribe to
×